razoxane has been researched along with Cancer of Gastrointestinal Tract in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, AJ; Joshi, R; Phillips, RH; Smith, B | 1 |
| Ashford, RF; Bakowski, M; Evans, M; Hellman, K; Jones, R; Lambert, J; Newton, K; Peters, N; Phillips, R; Smith, BJ | 1 |
| Bruckner, HW; Lokich, JJ; Stablein, DM | 1 |
| Moertel, CG | 1 |
| Catalano, RB; Engstrom, PF; Paul, AR | 1 |
| Bartolucci, A; DeSimone, PA; Greco, FA; Omura, GA | 1 |
1 trial(s) available for razoxane and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
Topics: Adenocarcinoma; Clinical Trials as Topic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Piperazines; Prognosis; Razoxane; Rectal Neoplasms; Stomach Neoplasms | 1983 |
5 other study(ies) available for razoxane and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Acute myelomonocytic leukaemia after razoxane therapy.
Topics: Female; Gastrointestinal Neoplasms; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Razoxane | 1981 |
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
Topics: Adenocarcinoma; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Humans; Male; Methotrexate; Middle Aged; Myeloproliferative Disorders; Prognosis; Random Allocation; Razoxane; Triazines | 1982 |
Chemotherapy of gastrointestinal cancer.
Topics: Doxorubicin; Floxuridine; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Mitomycins; Nitrosourea Compounds; Pancreatic Neoplasms; Razoxane; Streptozocin | 1976 |
Phase I trial of ICRF-159 in combination with 1.3 bis-(2-chloroethyl)-1-nitrosourea (MeCCNU).
Topics: Bone Marrow; Drug Evaluation; Drug Therapy, Combination; Gastrointestinal Neoplasms; Humans; Neoplasms; Piperazines; Razoxane; Semustine | 1978 |
Phase I-II evaluation of razoxane (ICRF-159) and doxorubicin in gastrointestinal cancer. A Southeastern Cancer Study Group Trial.
Topics: Adenocarcinoma; Agranulocytosis; Drug Evaluation; Gastrointestinal Neoplasms; Humans; Piperazines; Razoxane | 1986 |